Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  FGFR inhibitor TAS-120
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Dose Finding Study Followed by a Safety and Efficacy Study in Patients With Advanced Solid Tumors or Multiple Myeloma With FGF/FGFR-Related Abnormalities
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: TPU-TAS-120-101, NCI-2014-01148, NCT02052778
Start Over